160 likes | 287 Views
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s P rogrammes at the University of Pécs and at the University of Debrecen Identification number : TÁMOP-4.1.2-08/1/A-2009-0011.
E N D
Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identificationnumber: TÁMOP-4.1.2-08/1/A-2009-0011
Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Dr. Judit Pongrácz Threedimensionaltissuecultures and tissueengineering – Lecture 11 Cell-Scaffoldinteraction
ScaffoldsI • Pre-made network of biomaterial • One cell type seeded on one scaffold • Several cell types seeded on a scaffold simultaneously or sequentially
ScaffoldsII Fleece Fusedbeeds CO2 Fusedirregular Fusedcubeporogen Cubeporogen
Cell line cells nestling on a scaffold A549 (lung adenocarcinoma cell line)
Matrigel® • Matrigel: • is the trade name for a gelatinous protein mixture secreted by mouse sarcoma cells • This mixture resembles the complex extracellular environment found in many tissues • Matrigel is marketed by BD Biosciences
Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Dr. Judit Pongrácz Threedimensionaltissuecultures and tissueengineering – Lecture 12 Biofactors
Biofactors Adjacentcell Wnt Wnt Cytosol Frizzled FGF GSK3 BMP Disheveled FGF receptor b-TrCP b-catenin accumulation b-catenin degradation PI3K TGF-b PLCg Nucleus Jaggedor Delta-like ligands BMP and TGF-breceptor TCF SMAD ATF2 Elk1 TAK Hey ATF2 c-fos c-jun Notch Proliferation Differentiation Migration ICD HES
Main growthfactors (GFs) used in tissue engineering • VEGF– vascularendothelialgrowthfactor • KGF – keratinocytegrowthfactor • TGF-b– transfrominggrowthfactorbeta • BMP– bonemorphogenic protein • FGF– fibroblastgrowthfactor • PDGF– platelet-derivedgrowthfactor
VEGF • Primarilyinendothelialcells • Dimericglycoprotein • Foursplicevariants • Receptors: VEGFR-1 and VEGFR-2
TGF-b • Superfamilymember • MW 21 kDa • Synthesizedbyplatelets and macrophages • Inducesdifferentiationinmultiplecelltypes of varioustissues
BMP • Osteoinductivepeptidefamily • BelongstotheTGF-bsuperfamily • MW 25-30 kDa
FGF • 23 members of thefamily • Multiplefunctionsonmultiplecelltypes • Human FGF-2 18 kDanon-glycosylatedpolypeptidebindstoheparin and heparansulfate
PDGF • Existsas a dimer • Twochains MW 14-17 kDaeach • Synthesizedbyplatelets, macrophages, endothelium, connectivetissue • Effects: Mitogenesis, angiogenesis, macrophageactivation
Delivery of growthfactors • Injected • Diffusedfromscaffolds • Releasedfromgels • Geneticallyengineeredintocells